GI Innovation allergic diseases treatment

With South Korea setting new lows in birth rate every year, PharmaResearch on Wednesday said it will adopt an unprecedented system of childbirth and...

Hyundai Doosan Infracore Co., a construction machinery subsidiary of HD Hyundai Group, announced on Tuesday that its 14-ton hybrid electric wheel ex...

South Korean biotech GI Innovation Inc. is slated to debut on the local public market at less than half of its pre-IPO investment value, facing luke...

Toray Advanced Materials Korea Inc. announced on Monday the acquisition of Hanmee Entec Co., Ltd., the industry's longest-running water treatment fa...

Prestige Biopharma, a biopharmaceutical company in South Korea, announced on Thursday that their pancreatic cancer antibody drug, PBP1510 (Ulenistam...

Hyundai Construction Equipment Co., a construction equipment subsidiary of HD Hyundai Co., announced on Thursday the release of its new brand identi...

LS Electric Co., Ltd., an industrial electric solutions company from South Korea, is set to showcase innovative solutions at smart energy exhibition...

South Korean pharmaceutical company Daewoong Pharmaceutical announced on Tuesday that it has received marketing authorization from Chile's National ...

South Korea's OliX Pharmaceuticals has received approval from Australia's Human Research Ethics Committees (HREC) to plan a phase 1 clinical trial o...

South Korea-based global marketing communications company Innocean said on Thursday that it received eight awards at the 2023 Spikes Asia, a prestig...

South Korea's food and bio giant CJ CheilJedang Corp. on Sunday said it opened Inno Play, an office space for commercializing innovative ideas and d...

Samsung Bioepis Co., a South Korean biosimilar firm, announced on Sunday that it has recently launched a new biosimilar drug called SB11 for the tre...

Musinsa, a fashion e-commerce platform based in South Korea, on Friday was named one of this year's "Top-10 Most Innovative Companies in Asia-Pacifi...

South Korea's GC Biopharma Corp. announced on Tuesday that it had entered into an agreement to transfer assets with Catalyst Biosciences, a US-based...

South Korea’s Hanwha Techwin on Wednesday changed its name to Hanwha Vision and unveiled its new corporate image. On the reason for the n...

Samsung Electronics Co. has opened its first regional C-Lab Outside campus in Daegu – where its founder Lee Byung-chull started his first busi...

South Korea’s health and drug safety authority has cleared Somzz to treat patients with sleep disorders, a dynamic move that is expected to vi...

Ford Motor Co. said on Tuesday it has stopped production and shipments of the F-150 Lightning electric pickup truck due to a possible battery issue,...

South Korea's Daesang Wellife Corp. has inked a 2 billion won ($1.5 million) investment contract with local healthcare data science company RexSoft ...

Vaxcell-Bio Therapeutics, a South Korean company specializing in anti-cancer immunotherapy, announced on Wednesday its partnership with Cellid Co. t...

South Korea's EcoPro Co., a leading cathode supplier for global battery makers, is expanding its plant for raw materials used in secondary battery c...

South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...

SK Plasma Co. Ltd., a South Korean company specializing in the production of plasma derivatives from human plasma, is expanding its product portfoli...

South Korean pharmaceuticals firm Hanall Biopharma Co. is investing in Interon Laboratories, a US biotech firm that finds and develops treatments fo...

South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...

South Korean medical devices maker, Humasis Co., is participating in the MEDLAB Middle East 2023 event taking place at the Dubai World Trade Center ...

SK Innovation Co., the refinery and chemicals unit of South Korea’s second-largest conglomerate SK, is poised to strengthen its eco-friendly b...

South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...

South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...

South Korea's biohealth company HK inno.N said on Wednesday that it has signed an agreement with Spanish pharmaceutical company mAbxience SA to intr...